相关实验视频

Updated: Sep 12, 2025

Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens

Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens

Published on: December 17, 2019

基于多奥米克分析的高性心肌病中受CX3CL1介导的受损内皮细胞衍生的巨细胞效

Yan Zhang¹, Xin Yan², Xiao-Lei Fu²

¹Department of Anesthesiology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan Province, China.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

|August 5, 2025

概括

降低的CX3CL1会损害巨细胞增生,这是导致心肌缩症 (HCM) 发展的关键因素. 增强CX3CL1可能为管理HCM进展提供新的治疗策略.

科学领域:

心血管生物学心血管生物学
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

炎症蛋白与多变性心肌病 (HCM) 有关,但它们在疾病发展中的确切作用尚不清楚.
了解这些炎症途径对于识别HCM的新型治疗点至关重要.

研究的目的:

调查炎症蛋白质,特别是CX3CL1在缩性心肌病变 (HCM) 发病过程中的作用.
探索向CX3CL1用于管理HCM进展的潜力.

主要方法:

门德尔随机化 (MR) 分析,以评估炎症蛋白和HCM之间的关联.
生物信息学,体内和体外模型,以阐明CX3CL1在HCM中的功能作用.
对心肌细胞和内皮细胞中CX3CL1表达的分析,以及其与巨细胞发生的关联.

主要成果:

核磁共振分析显示,CX3CL1和HCM之间存在负相关性.
在HCM中,CX3CL1的表达显著降低,特别是在心肌细胞和内皮细胞中,并进一步由血管新素II降低.
CX3CL1与巨细胞增多症有很强的关联,在HCM中减少了细胞增多症标志物 (AXL,MERTK,TYRO3) 的表达,这一过程被重组CX3CL1逆转.

结论:

由CX3CL1介导的受损的巨细胞细胞分裂在HCM的开始和进展中至关重要.
调节CX3CL1水平为管理多变性心肌病症提供了潜在的治疗途径.

关键词:

在CX3CL1中.有效的细胞分裂.过度缩性心肌病变性是一种心脏病变.与炎症相关的蛋白质.多个omics的多个omics.

更多相关视频

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...